Hot Undervalued Stocks For 2019

Peter Krauth

After hitting a distinct bottom early in the last week, silver prices have already bounced back impressively despite ongoing U.S. dollar strength. After starting May near $16.25, the price of silver rallied to a high near $16.47 last week.

The other challenge that silver faced was the news the market awaited from the FOMC meeting on Wednesday, May 2. After the meeting, the committee announced that it would not be hiking interest rates and said inflation continues to move higher.

After peaking on Tuesday, May 1, the gold/silver ratio has quietly begun trending downward once again. I think this is in recognition of silver’s underperformance and undervalued state relative to gold.

Hot Undervalued Stocks For 2019: RELX PLC(RELX)

Advisors’ Opinion:

  • [By Max Byerly]

    Oppenheimer Asset Management Inc. decreased its position in RELX Group (NYSE:RELX) by 33.1% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 26,655 shares of the technology company’s stock after selling 13,198 shares during the period. Oppenheimer Asset Management Inc.’s holdings in RELX Group were worth $557,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Relx (NYSE: RELX) and Cambium Learning Group (NASDAQ:ABCD) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

Hot Undervalued Stocks For 2019: Aphria Inc. (APHQF)

Advisors’ Opinion:

  • [By Keith Speights]

    Should Aurora actually buy MedReleaf, there could be considerable pressure on Canopy to make an acquisition of its own. One obvious target to buy would be Aphria (NASDAQOTH:APHQF), which has roughly the same market cap as MedReleaf. But would this acquisition make sense for Canopy Growth? I think it could.

  • [By Javier Hasse]

    Here are some of the top marijuana stocks in U.S. exchanges and how the performed over the last five trading days (percentages reflect approximate equity moves as of the time of the writing of this article.

    22nd Century Group Inc (NYSE: XXII): up 4.5 percent
    Aphria Inc (OTC: APHQF): down 1.4 percent
    Aurora Cannabis Inc (OTC: ACBFF): up 0.6 percent
    Cannabis Sativa Inc (OTC: CBDS): down 6.3 percent
    CannTrust Holdings Inc (OTC: CNTTF): down 3.3 percent
    Canopy Growth Corp (NYSE: CGC): up 1.8 percent
    Cronos Group Inc. (NASDAQ: CRON): up 9.3 percent
    GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH): up 2.2 percent
    Hiku Brands Company Ltd(OTC: DJACF): down 15.5 percent
    India Globalization Capital, Inc. (NYSE: IGC): down 1.9 percent
    iAnthus Capital Holdings Inc (OTC: ITHUF): up 4.6 percent
    MassRoots Inc (OTC: MSRT): down 0.2 percent
    MedReleaf Corp(OTC: MEDFF): up 1.1 percent
    Scotts Miracle-Gro Co (NYSE: SMG): down 3.6 percent
    THC Biomed Intl Ltd (OTC: THCBF): down 5.5 percent
    Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE): up 7.3 percent
    In Other News

    A consortium of cannabis-related media professionals are conducting a Cannabis Media Survey. You can answer following this link.

  • [By Keith Speights]

    Most Canadian marijuana stocks, including Canopy Growth (NYSE:CGC), Aurora Cannabis (NASDAQOTH:ACBFF), and Aphria (NASDAQOTH:APHQF), jumped on Wednesday after the historic vote. What’s next? There will likely be five phases Canadian marijuanastocks will experience.

  • [By SEEKINGALPHA.COM]

    Yesterday we wrote that we saw rampant red flags with Aphrias (OTCQB:APHQF) proposed Nuuvera (OTC:NUUVF) transaction. In particular, the transaction seemed to make little economic or strategic sense, and we had found it worrying that a self-described Aphria advisor named Andy DeFrancesco seemed to have business dealings with both sides of the deal.

Hot Undervalued Stocks For 2019: Exelixis, Inc.(EXEL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Exelixis (EXEL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Exelixis (NASDAQ:EXEL) EVP Jeffrey Hessekiel sold 20,000 shares of the company’s stock in a transaction dated Friday, May 4th. The stock was sold at an average price of $22.36, for a total transaction of $447,200.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

  • [By Stephan Byrd]

    Exelixis, Inc. (NASDAQ:EXEL) VP Patrick J. Haley sold 3,663 shares of the business’s stock in a transaction dated Friday, May 18th. The stock was sold at an average price of $21.61, for a total transaction of $79,157.43. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Exelixis (EXEL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Brian Orelli]

    Exelixis (NASDAQ:EXEL) and Bristol-Myers continue their love-hate relationship with results from a trial testing Exelixis’ Cabometyx and Opdivo in patients with urothelial carcinoma. The duo are already testing the combination in a phase 3 trial called CheckMate 9ER, so investors are looking for this updated data to give them confidence that the combination is continuing to work.

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    With that in mind, we asked a team of Motley Fool investors to highlight a biotech stock that they think is a strong buy right now. Here’s why they picked Exelixis (NASDAQ:EXEL), Celgene (NASDAQ:CELG), and Ionis Pharmaceuticals (NASDAQ:IONS).

Hot Undervalued Stocks For 2019: Preferred Apartment Communities, Inc.(APTS)

Advisors’ Opinion:

  • [By Max Byerly]

    WINTON GROUP Ltd acquired a new stake in Preferred Apartment Communities Inc. (NYSE:APTS) during the 1st quarter, Holdings Channel reports. The firm acquired 80,485 shares of the real estate investment trust’s stock, valued at approximately $1,142,000.

  • [By Joseph Griffin]

    Preferred Apartment (NYSE:APTS) – Research analysts at B. Riley raised their FY2018 earnings estimates for shares of Preferred Apartment in a note issued to investors on Thursday, May 3rd. B. Riley analyst C. Kucera now expects that the real estate investment trust will post earnings per share of $1.45 for the year, up from their prior estimate of $1.44. B. Riley currently has a “Hold” rating and a $16.00 price target on the stock. B. Riley also issued estimates for Preferred Apartment’s Q4 2018 earnings at $0.40 EPS.

  • [By Ethan Ryder]

    Stratos Wealth Partners LTD. lifted its stake in shares of Preferred Apartment Communities Inc. (NYSE:APTS) by 135.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 14,089 shares of the real estate investment trust’s stock after purchasing an additional 8,113 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Preferred Apartment Communities were worth $200,000 as of its most recent SEC filing.

Hot Undervalued Stocks For 2019: Recon Technology, Ltd.(RCON)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media coverage about Recon Technology (NASDAQ:RCON) has been trending positive recently, Accern Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Recon Technology earned a media sentiment score of 0.27 on Accern’s scale. Accern also assigned media headlines about the oil and gas company an impact score of 44.9374991541436 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Leave a Reply

Your email address will not be published. Required fields are marked *